Endymed
Endymed Ltd provides energy based medical aesthetic treatment systems for the professional and consumer markets in North America, Europe, the Middle East, Africa, Asia, Oceania, Latin America, and internationally. The company offers ENDYMED PRO, an all-in-one treatment platform; ENDYMED PURE 2.0, a compact and flexible treatment platform; Pure Laser, a laser hair removal system; Intensif, a RF mi… Read more
Market Cap & Net Worth: Endymed (ENDY)
Endymed (TA:ENDY) has a market capitalization of $11.81 Million (ILA4.41 Billion) as of March 18, 2026. Listed on the TA stock exchange, this Israel-based company holds position #40586 globally and #370 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Endymed's stock price ILA320.10 by its total outstanding shares 13762100 (13.76 Million).
Endymed Market Cap History: 2015 to 2025
Endymed's market capitalization history from 2015 to 2025. Data shows change from $44.94 Million to $11.81 Million (-13.76% CAGR).
Endymed Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Endymed's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.47x
Endymed's market cap is 0.47 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
19.28x
Endymed's market cap is 19.28 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $44.94 Million | $12.95 Million | -$3.83 Million | 3.47x | N/A |
| 2016 | $19.33 Million | $14.25 Million | -$3.31 Million | 1.36x | N/A |
| 2017 | $9.67 Million | $17.54 Million | -$2.70 Million | 0.55x | N/A |
| 2018 | $7.89 Million | $18.45 Million | $2.02 Million | 0.43x | 3.90x |
| 2019 | $7.19 Million | $16.45 Million | $1.75 Million | 0.44x | 4.12x |
| 2020 | $10.33 Million | $14.35 Million | $308.00K | 0.72x | 33.54x |
| 2021 | $26.38 Million | $21.78 Million | $5.16 Million | 1.21x | 5.11x |
| 2022 | $9.02 Million | $21.33 Million | $850.00K | 0.42x | 10.61x |
| 2023 | $10.66 Million | $22.78 Million | $553.00K | 0.47x | 19.28x |
Competitor Companies of ENDY by Market Capitalization
Companies near Endymed in the global market cap rankings as of March 18, 2026.
Key companies related to Endymed by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Endymed Historical Marketcap From 2015 to 2025
Between 2015 and today, Endymed's market cap moved from $44.94 Million to $ 11.81 Million, with a yearly change of -13.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ILA11.81 Million | +4.95% |
| 2024 | ILA11.25 Million | +5.54% |
| 2023 | ILA10.66 Million | +18.20% |
| 2022 | ILA9.02 Million | -65.80% |
| 2021 | ILA26.38 Million | +155.36% |
| 2020 | ILA10.33 Million | +43.59% |
| 2019 | ILA7.19 Million | -8.79% |
| 2018 | ILA7.89 Million | -18.40% |
| 2017 | ILA9.67 Million | -50.00% |
| 2016 | ILA19.33 Million | -56.98% |
| 2015 | ILA44.94 Million | -- |
End of Day Market Cap According to Different Sources
On Feb 15th, 2026 the market cap of Endymed was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.81 Million USD |
| MoneyControl | $11.81 Million USD |
| MarketWatch | $11.81 Million USD |
| marketcap.company | $11.81 Million USD |
| Reuters | $11.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.